Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Santaris and miRagen develop microRNA-targeted cardiovascular medicines

June 28, 2010

Amorfix and QED to co-develop high-affinity monoclonal antibodies for cancer

June 28, 2010

GSK and Prosensa expand development of DMD treatments

June 25, 2010

Medivir and GSK to market Xerclear for treatment of cold sores

June 25, 2010

Sanofi-aventis and Regulus collaborate on microRNA therapeutics

June 23, 2010

Exelixis regains rights to XL-184

June 22, 2010

CanBas and Takeda to terminate collaboration for anticancer agent CBP-501

June 21, 2010

Neurocrine and Boehringer to develop GPR119 agonists for type 2 diabetes

June 21, 2010

OncoMed and Bayer Schering form anticancer stem cell alliance

June 18, 2010

Abbott and Neurocrine join to develop elagolix for endometriosis

June 18, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...